,
“Assessing quality of life in head and neck cancer.”, Qual Life Res, vol. 1, no. 1, pp. 5-17, 1992.
, “Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.”, Clin Infect Dis, vol. 59 Suppl 7, pp. S428-36, 2014.
, “Assessment of Congenital Anomalies in Infants Born to Pregnant Women Enrolled in Clinical Trials”, Clin Infect Dis, vol. 59 Suppl 7, pp. S428-436, 2014.
, “Assessment of family history information in case-control cancer studies.”, Am J Epidemiol, vol. 133, no. 8, pp. 757-65, 1991.
, “Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome.”, Front Pediatr, vol. 3, p. 49, 2015.
, “Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome”, Front Pediatr, vol. 3, 2015.
, “Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.”, Clin Infect Dis, vol. 59 Suppl 7, pp. S415-27, 2014.
, “Assessment of Safety in Newborns of Mothers Participating in Clinical Trials of Vaccines Administered During Pregnancy”, Clin Infect Dis, vol. 59 Suppl 7, pp. S415-427, 2014.
, “Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents”, JAMA Netw Open, vol. 6, no. 5, p. e2314422, 2023.
, “Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.”, JAMA Netw Open, vol. 2, no. 9, p. e1910769, 2019.
, “An assessment of the perceived benefits and challenges of participating in a practice-based research network.”, Prim Dent J, vol. 1, no. 1, pp. 50-7, 2012.
, “An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network”, Prim Dent J, vol. 1, pp. 50-57, 2012.
, “Assessment of the Psychometric Properties of a Questionnaire Assessing Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL).”, JAMA Ophthalmol, vol. 135, no. 1, pp. 3-12, 2017.
, , “Association Between Clinical Risk Factors and Progression of Chronic Kidney Disease in Children”, Clin J Am Soc Nephrol, vol. 5, pp. 2172-2179, 2010.
, “Association between clinical risk factors and progression of chronic kidney disease in children.”, Clin J Am Soc Nephrol, vol. 5, no. 12, pp. 2172-9, 2010.
, “Association between C-reactive protein and age-related macular degeneration.”, JAMA, vol. 291, no. 6, pp. 704-10, 2004.
, “Association between C-Reactive Protein and Macular Degeneration”, JAMA, vol. 291, pp. 704-710, 2004.
, “Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 86, no. 1, pp. 180-8, 2007.
, “Association between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study (AREDS)”, Am J Clin Nutr, vol. 86, pp. 180-188, 2007.
, “Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.”, Graefes Arch Clin Exp Ophthalmol, vol. 239, no. 7, pp. 1839-1851, 2021.
, “Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.”, Lancet Diabetes Endocrinol, vol. 11, no. 6, pp. 391-401, 2023.
, “Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22.”, JAMA Ophthalmol, 2020.
, “The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”, Ophthalmology, vol. 126, no. 12, pp. 1647-1656, 2019.
,